NCT02113683View on ClinicalTrials.gov

Validation of MMS Test for Cancer Monitoring

TerminatedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 20, 2018

Study Completion Date

June 20, 2018

Conditions

Colo-rectal CancerStomach CancerMelanomaSarcoma

Trial Locations (1)

13125

HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie, Berlin

Sponsors

Lead Sponsor

MedInnovation GmbH

All Listed Sponsors

collaborator

Helios Klinikum Berlin-Buch

OTHER

lead

MedInnovation GmbH

INDUSTRY

NCT02113683 - Validation of MMS Test for Cancer Monitoring | Biotech Hunter | Biotech Hunter